| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Pharmacology (S.C., R.S.), University of Bristol; and Institute of Membrane & Systems Biology (J.C.), University of Leeds, UK.
Correspondence to Rebecca Sitsapesan, University of Bristol, Department of Pharmacology, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK. E-mail r.sitsapesan{at}bris.ac.uk
It is suggested that protein kinase A (PKA)-dependent phosphorylation of cardiac ryanodine receptors (RyR2) is linked to the development of heart failure and the generation of fatal cardiac arrhythmias. It is also suggested that RyR2 is phosphorylated to 75% of maximum levels in heart failure resulting in leaky, unregulated channels gating in subconductance states. We now demonstrate that this is unlikely, as RyR2 isolated from nonfailing cardiac muscle is phosphorylated to 75% of maximum at serine-2809, and in this situation, RyR2 displays low open probability (Po) (0.059±0.010 [SEM]; n=30) and normal regulation of gating by Ca2+ and other ligands. However, when serine-2809 is PKA phosphorylated to maximum levels on RyR2, unique changes in channel behavior are observed. The channel displays enhanced single-channel conductance, very long open states causing large increases in Po, and no evidence of subconductance states. Dephosphorylation of channels by protein phosphatase 1 (from 75% to near 0% at serine-2809) also enhances RyR2 channel activity through abbreviation of closed lifetimes. We propose that channels phosphorylated to 75% of maximum at serine-2809 occupy a natural low point in the RyR2 activity landscape. This optimizes channel control, which can be accomplished either by enhanced or decreased phosphorylation, making the channel particularly sensitive to the kinase:phosphatase balance. Pathological situations such as heart failure might upset this balance and thereby permit prolonged stoichiometric phosphorylation of serine-2809, which would be required for dysregulation of SR Ca2+ release.
Key Words: phosphorylation ryanodine receptor Ca2+ release excitationcontraction coupling
This article has been cited by other articles:
![]() |
P. Zhou, Y.-T. Zhao, Y.-B. Guo, S.-M. Xu, S.-H. Bai, E. G. Lakatta, H. Cheng, X.-M. Hao, and S.-Q. Wang {beta}-Adrenergic signaling accelerates and synchronizes cardiac ryanodine receptor response to a single L-type Ca2+ channel PNAS, October 20, 2009; 106(42): 18028 - 18033. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Blayney, J.-L. Jones, J. Griffiths, and F. A. Lai A mechanism of ryanodine receptor modulation by FKBP12/12.6, protein kinase A, and K201 Cardiovasc Res, September 2, 2009; (2009) cvp273v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hamilton and I. I. Serysheva Ryanodine Receptor Structure: Progress and Challenges J. Biol. Chem., February 13, 2009; 284(7): 4047 - 4051. [Full Text] [PDF] |
||||
![]() |
Y.-H. Yeh, R. Wakili, X.-Y. Qi, D. Chartier, P. Boknik, S. Kaab, U. Ravens, P. Coutu, D. Dobrev, and S. Nattel Calcium-Handling Abnormalities Underlying Atrial Arrhythmogenesis and Contractile Dysfunction in Dogs With Congestive Heart Failure Circ Arrhythm Electrophysiol, June 1, 2008; 1(2): 93 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhu, A. A. Gach, G. Liu, X. Xu, C. C. Lim, J. X. Zhang, L. Mao, K. Chuprun, W. J. Koch, R. Liao, et al. Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G{alpha}o* protein Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1335 - H1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikeda, M. Hoshijima, and K. R. Chien Toward Biologically Targeted Therapy of Calcium Cycling Defects in Heart Failure Physiology, February 1, 2008; 23(1): 6 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. George Sarcoplasmic reticulum Ca2+ leak in heart failure: mere observation or functional relevance? Cardiovasc Res, January 15, 2008; 77(2): 302 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. James Inhibition of SR Ca2+ uptake: A novel action of the RyR2-FKBP12.6 antagonist K201 Cardiovasc Res, November 1, 2007; 76(2): 199 - 201. [Full Text] [PDF] |
||||
![]() |
B. Xiao, X. Tian, W. Xie, P. P. Jones, S. Cai, X. Wang, D. Jiang, H. Kong, L. Zhang, K. Chen, et al. Functional Consequence of Protein Kinase A-dependent Phosphorylation of the Cardiac Ryanodine Receptor: SENSITIZATION OF STORE OVERLOAD-INDUCED Ca2+ RELEASE J. Biol. Chem., October 12, 2007; 282(41): 30256 - 30264. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Benkusky, C. S. Weber, J. A. Scherman, E. F. Farrell, T. A. Hacker, M. C. John, P. A. Powers, and H. H. Valdivia Intact {beta}-Adrenergic Response and Unmodified Progression Toward Heart Failure in Mice With Genetic Ablation of a Major Protein Kinase A Phosphorylation Site in the Cardiac Ryanodine Receptor Circ. Res., October 12, 2007; 101(8): 819 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Seidler, G. Hasenfuss, and L. S. Maier Targeting Altered Calcium Physiology in the Heart: Translational Approaches to Excitation, Contraction, and Transcription Physiology, October 1, 2007; 22(5): 328 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pereira, M. Metrich, M. Fernandez-Velasco, A. Lucas, J. Leroy, R. Perrier, E. Morel, R. Fischmeister, S. Richard, J.-P. Benitah, et al. The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes J. Physiol., September 1, 2007; 583(2): 685 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kockskamper and B. Pieske Phosphorylation of the Cardiac Ryanodine Receptor by Ca2+/Calmodulin-Dependent Protein Kinase II: The Dominating Twin of Protein Kinase A? Circ. Res., August 18, 2006; 99(4): 333 - 335. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |